DMBT1 as an archetypal link between infection, inflammation, and cancer

Balkwill, 2001, Inflammation and cancer: back to Virchow?, Lancet, 357, 539, 10.1016/S0140-6736(00)04046-0 Karin, 2006, Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer, Cell, 124, 823, 10.1016/j.cell.2006.02.016 Ogura, 2001, A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease, Nature, 411, 603, 10.1038/35079114 Hugot, 2001, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature, 411, 599, 10.1038/35079107 Hampe, 2001, Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations, Lancet, 357, 1925, 10.1016/S0140-6736(00)05063-7 Watanabe, 2004, NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses, Nat Immunol, 5, 800, 10.1038/ni1092 Maeda, 2005, Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1, processing, Science, 307, 734, 10.1126/science.1103685 Kobayashi, 2005, Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract, Science, 307, 731, 10.1126/science.1104911 Kim, 1995, Diversity of mucin genes, structure, function, and expression, Gastroenterology, 109, 999, 10.1016/0016-5085(95)90412-3 Corfield, 2001, Mucins in the gastrointestinal tract in health and disease, Front Biosci, 6, D1321, 10.2741/Corfield Velcich, 2002, Colorectal cancer in mice genetically deficient in the mucin Muc2, Science, 295, 1726, 10.1126/science.1069094 Hudson, 2001, Human MUC1 mucin: A potent glandular morphogen, J Pathol, 194, 373, 10.1002/1096-9896(200107)194:3<373::AID-PATH898>3.0.CO;2-6 Lehrer, 2004, Primate defensins, Nat Rev Microbiol, 2, 727, 10.1038/nrmicro976 Markeeva, 2005, Involvement of human beta-defensin-2 in proliferation of transformed cells of human cervix, Exp Oncol, 27, 308 Sun, 2006, Human beta-defensin-1, a potential chromosome 8p tumor suppressor: Control of transcription and induction of apoptosis in renal cell carcinoma, Cancer Res, 66, 8542, 10.1158/0008-5472.CAN-06-0294 Bullard, 2008, Functional analysis of the host defense peptide Human Beta Defensin-1: New insight into its potential role in cancer, Mol Immunol, 45, 839, 10.1016/j.molimm.2006.11.026 Mollenhauer, 1997, DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours, Nat Genet, 17, 32, 10.1038/ng0997-32 Mollenhauer, 1999, The genomic structure of the DMBT1 gene: Evidence for a region with susceptibility to genomic instability, Oncogene, 18, 6233, 10.1038/sj.onc.1203071 Holmskov, 1999, Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D, Proc Natl Acad Sci USA, 96, 10794, 10.1073/pnas.96.19.10794 Mollenhauer, 2001, Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer, Cancer Res, 61, 8880 Cheng, 1996, CRP-ductin: A gene expressed in intestinal crypts and in pancreatic and hepatic ducts, Anat Rec, 244, 327, 10.1002/(SICI)1097-0185(199603)244:3<327::AID-AR5>3.0.CO;2-V Li, 1995, Molecular cloning of Ebnerin, a von Ebner's gland protein associated with taste buds, J Biol Chem, 270, 17674, 10.1074/jbc.270.30.17674 Matsushita, 2000, Vomeroglandin/CRP-Ductin is strongly expressed in the glands associated with the mouse vomeronasal organ: Identification and characterization of mouse vomeroglandin, Biochem Biophys Res Commun, 268, 275, 10.1006/bbrc.2000.2104 De Lisle, 2000, Processing of pro-Muclin and divergent trafficking of its products to zymogen granules and the apical plasma membrane of pancreatic acinar cells, Eur J Cell Biol, 79, 892, 10.1078/0171-9335-00121 Tandon, 2004, Apactin is involved in remodeling of the actin cytoskeleton during regulated exocytosis, Eur J Cell Biol, 83, 79, 10.1078/0171-9335-00361 Madsen, 2003, CRP-ductin, the mouse homologue of gp-340/deleted in malignant brain tumors 1 (DMBT1), binds gram-positive and gram-negative bacteria and interacts with lung surfactant protein D, Eur J Immunol, 33, 2327, 10.1002/eji.200323972 Mollenhauer, 2002, Sequential changes of the DMBT1 expression and location in normal lung tissue and lung carcinomas, Genes Chromosomes Cancer, 35, 164, 10.1002/gcc.10096 Padilla, 2002, Cloning of S4D-SRCRB, a new soluble member of the group B scavenger receptor cysteine-rich family (SRCR-SF) mapping to human chromosome 7q11.23, Immunogenetics, 54, 621, 10.1007/s00251-002-0507-z Mollenhauer, 2000, DMBT1 encodes a protein involved in the immune defense and in epithelial differentiation and is highly unstable in cancer, Cancer Res, 60, 1704 Mollenhauer, 2002, The SRCR/SID region of DMBT1 defines a complex multi-allele system representing the major basis for its variability in cancer, Genes Chromosomes Cancer, 35, 242, 10.1002/gcc.10115 Sasaki, 2002, DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis, Cancer Res, 62, 1790 Pang, 2003, Mutation analysis of DMBT1 in glioblastoma, medulloblastoma and oligodendroglial tumors, Int J Cancer, 105, 76, 10.1002/ijc.11019 Mollenhauer, 2004, Carcinogen inducibility in vivo and down-regulation of DMBT1 during breast carcinogenesis, Genes Chromosomes Cancer, 39, 185, 10.1002/gcc.10309 Wu, 1999, Expression of DMBT1, a candidate tumor suppressor gene, is frequently lost in lung cancer, Cancer Res, 59, 1846 Takeshita, 1999, Expression of the DMBT1 gene is frequently suppressed in human lung cancer, Jpn J Cancer Res, 90, 903, 10.1111/j.1349-7006.1999.tb00833.x Petersen, 2000, Analysis of the DMBT1 gene in carcinomas of the respiratory tract, Int J Cancer, 88, 71, 10.1002/1097-0215(20001001)88:1<71::AID-IJC11>3.0.CO;2-X Mueller, 2002, Rare mutations of the DMBT1 gene in human astrocytic gliomas, Oncogene, 21, 5956, 10.1038/sj.onc.1205733 Mollenhauer, 2003, Frequent downregulation of DMBT1 and galectin-3 in epithelial skin cancer, Int J Cancer, 105, 149, 10.1002/ijc.11072 Mori, 1999, Lack of DMBT1 expression in oesophageal, gastric and colon cancers, Br J Cancer, 79, 211, 10.1038/sj.bjc.6690035 Sasaki, 2003, Decrease of deleted in malignant brain tumour-1 (DMBT-1) expression is a crucial late event in intrahepatic cholangiocarcinoma, Histopathology, 43, 340, 10.1046/j.1365-2559.2003.01719.x Braidotti, 2004, DMBT1 expression is down-regulated in breast cancer, BMC Cancer, 4, 46, 10.1186/1471-2407-4-46 Inda, 2004, PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors, Oncol Rep, 12, 1341 Imai, 2005, Down-regulation of DMBT1 gene expression in human oral squamous cell carcinoma, Int J Mol Med, 15, 585 Kang, 2005, Induction of DMBT1 expression by reduced ERK activity during a gastric mucosa differentiation-like process and its association with human gastric cancer, Carcinogenesis, 26, 1129, 10.1093/carcin/bgi045 Conde, 2007, DMBT1 is frequently downregulated in well-differentiated gastric carcinoma but more frequently upregulated across various gastric cancer types, Int J Oncol, 30, 1441 Sasaki, 2002, Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines, Cancer Res, 62, 4894 Bikker, 2004, Salivary agglutinin/DMBT1SAG expression is up-regulated in the presence of salivary gland tumors, J Dent Res, 83, 567, 10.1177/154405910408300711 Hustinx, 2004, Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression, Cancer Biol Ther, 3, 1254, 10.4161/cbt.3.12.1238 Li, 2006, Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene, Carcinogenesis, 27, 1054, 10.1093/carcin/bgi324 Mollenhauer, 2002, An integrative model on the role of DMBT1 in epithelial cancer, Cancer Detect Prev, 26, 266, 10.1016/S0361-090X(02)00094-6 Marxfeld, 2006, Differentiation of spontaneous and induced mammary adenocarcinomas of the rat by gene expression profiling, Exp Toxicol Pathol, 58, 151, 10.1016/j.etp.2006.06.008 Genter, 2002, Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa, Physiol Genomics, 12, 35, 10.1152/physiolgenomics.00120.2002 Bisgaard, 2002, Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1, Am J Pathol, 161, 1187, 10.1016/S0002-9440(10)64395-7 Schwartz, 1985, Plasticity of functional epithelial polarity, Nature, 318, 368, 10.1038/318368a0 van Adelsberg, 1994, An induced extracellular matrix protein reverses the polarity of band 3 in intercalated epithelial cells, Cell, 76, 1053, 10.1016/0092-8674(94)90382-4 Takito, 1996, A new collecting duct protein involved in the in vitro plasticity of intercalated cell polarity, J Clin Invest, 98, 2324, 10.1172/JCI119044 Takito, 1999, Hensin, the polarity reversal protein, is encoded by DMBT1, a gene frequently deleted in malignant gliomas, Am J Physiol, 277, F277 Vijayakumar, 1999, Hensin remodels the apical cytoskeleton and induces columnarization of intercalated epithelial cells: processes that resemble terminal differentiation, J Cell Biol, 144, 1057, 10.1083/jcb.144.5.1057 Hikita, 1999, Only multimeric hensin located in the extracellular matrix can induce apical endocytosis and reverse the polarity of intercalated cells, J Biol Chem, 274, 17671, 10.1074/jbc.274.25.17671 Hikita, 2000, Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3, J Cell Biol, 151, 1235, 10.1083/jcb.151.6.1235 Watanabe, 2005, Cyclosporin A produces distal renal tubular acidosis by blocking peptidyl prolyl cis-trans isomerase activity of cyclophilin, Am J Physiol Renal Physiol, 288, F40, 10.1152/ajprenal.00218.2004 Takito, 2004, Conversion of ES cells to columnar epithelia by hensin and to squamous epithelia by laminin, J Cell Biol, 166, 1093, 10.1083/jcb.200405159 Gassler, 2006, Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine, Gut, 55, 1084, 10.1136/gut.2005.073262 Ward, 2004, Mouse models of human familial cancer syndromes, Toxicol Pathol, 32, 90, 10.1080/01926230490424680 Renner, 2007, DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's Disease, Gastroenterology, 133, 1499, 10.1053/j.gastro.2007.08.007 Blackburn, 2007, Genetic Mapping in Mice Identifies DMBT1 as a Candidate Modifier of Mammary Tumors and Breast Cancer Risk, Am J Pathol, 170, 2030, 10.2353/ajpath.2007.060512 Holmskov, 1997, Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule, J Biol Chem, 272, 13743, 10.1074/jbc.272.21.13743 Prakobphol, 2000, Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340, J Biol Chem, 275, 39860, 10.1074/jbc.M006928200 Ligtenberg, 2001, Human salivary agglutinin binds to lung surfactant protein-D and is identical with scavenger receptor protein gp-340, Biochem J, 359, 243, 10.1042/0264-6021:3590243 Ericson, 1983, Characterization of a salivary agglutinin reacting with a serotype c strain of Streptococcus mutans, Eur J Biochem, 133, 255, 10.1111/j.1432-1033.1983.tb07456.x Carlen, 1995, Monoclonal antibodies against a high-molecular-weight agglutinin block adherence to experimental pellicles on hydroxyapatite and aggregation of Streptococcus mutans, J Dent Res, 74, 1040, 10.1177/00220345950740040301 Carlen, 1996, Saliva-mediated binding in vitro and prevalence in vivo of Streptococcus mutans, Arch Oral Biol, 41, 35, 10.1016/0003-9969(95)00099-2 Carlen, 1998, Agglutinin and acidic proline-rich protein receptor patterns may modulate bacterial adherence and colonization on tooth surfaces, J Dent Res, 77, 81, 10.1177/00220345980770011301 Bikker, 2002, Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily, J Biol Chem, 277, 32109, 10.1074/jbc.M203788200 Rosenstiel, 2007, Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion, J Immunol, 178, 8203, 10.4049/jimmunol.178.12.8203 Nagashunmugam, 1998, Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus, J Infect Dis, 178, 1635, 10.1086/314511 Hartshorn, 2003, Lung and salivary scavenger receptor glycoprotein-340 contribute to the host defense against influenza A viruses, Am J Physiol Lung Cell Mol Physiol, 285, L1066, 10.1152/ajplung.00057.2003 Tino, 1999, Glycoprotein-340 binds surfactant protein-A (SPA) and stimulates alveolar macrophage migration in an SP-A-independent manner, Am J Respir Cell Mol Biol, 20, 759, 10.1165/ajrcmb.20.4.3439 Thornton, 2001, Identification of a nonmucin glycoprotein (gp-340) from a purified respiratory mucin preparation: evidence for an association involving the MUC5B mucin, Glycobiology, 11, 969, 10.1093/glycob/11.11.969 Boackle, 1993, High molecular weight non-immunoglobulin salivary agglutinins (NIA) bind C1Q globular heads and have the potential to activate the first complement component, Mol Immunol, 30, 309, 10.1016/0161-5890(93)90059-K Mitoma, 2001, Inhibitory effect of bovine milk lactoferrin on the interaction between a streptococcal surface protein antigen and human salivary agglutinin, J Biol Chem, 276, 18060, 10.1074/jbc.M101459200 Oho, 1998, Binding of salivary glycoprotein-secretory immunoglobulin A complex to the surface protein antigen of Streptococcus mutans, Infect Immun, 66, 115, 10.1128/IAI.66.1.115-121.1998 Thim, 2000, Isolation and characterization of putative trefoil peptide receptors, Regul Pept, 90, 61, 10.1016/S0167-0115(00)00110-5 Sasaki, 2004, Site-characteristic expression and induction of trefoil factor family 1, 2 and 3 and malignant brain tumor-1 in normal and diseased intrahepatic bile ducts relates to biliary pathophysiology, Liver Int, 24, 29, 10.1111/j.1478-3231.2004.00883.x Mueller, 2003, Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma, Proc Natl Acad Sci USA, 100, 1292, 10.1073/pnas.242741699 Hooper, 2001, Molecular analysis of commensal host-microbial relationships in the intestine, Science, 291, 881, 10.1126/science.291.5505.881 Rawls, 2004, Gnotobiotic zebrafish reveal evolutionarily conserved responses to the gut microbiota, Proc Natl Acad Sci USA, 101, 4596, 10.1073/pnas.0400706101 Kang, 2002, The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol ester, Clin Exp Immunol, 130, 449, 10.1046/j.1365-2249.2002.01992.x Gebel, 2006, The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression, Toxicol Sci, 93, 422, 10.1093/toxsci/kfl071 White, 2005, Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus, Am J Physiol Lung Cell Mol Physiol, 289, L606, 10.1152/ajplung.00130.2005 Liu, 2004, Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray, J Allergy Clin Immunol, 114, 783, 10.1016/j.jaci.2004.04.052 De Lisle, 1995, Increased expression of sulfated gp300 and acinar tissue pathology in pancreas of CFTR-/- mice, Am J Physiol, 268, 717 De Lisle, 1997, MUCLIN expression in the cystic fibrosis transmembrane conductance regulator knockout mouse, Gastroenterology, 113, 521, 10.1053/gast.1997.v113.pm9247472 Afdhal, 1993, Bovine gallbladder mucin accelerates cholesterol monohydrate crystal growth in model bile, Gastroenterology, 104, 1515, 10.1016/0016-5085(93)90364-I Nunes, 1995, Bovine gall-bladder mucin contains two distinct tandem repeating sequences: evidence for scavenger receptor cysteine-rich repeats, Biochem J, 310, 41, 10.1042/bj3100041 Nunes, 1999, A recombinant bovine gallbladder mucin polypeptide binds biliary lipids and accelerates cholesterol crystal appearance time, Gastroenterology, 116, 936, 10.1016/S0016-5085(99)70077-6 Sasaki, 2003, Expression of deleted in malignant brain tumor-1 (DMBT1) molecule in biliary epithelium is augmented in hepatolithiasis: possible participation in lithogenesis, Dig Dis Sci, 48, 1234, 10.1023/A:1024186504893 Schreiber, 2005, Genetics of Crohn disease, an archetypal inflammatory barrier disease, Nat Rev Genet, 6, 376, 10.1038/nrg1607 Fellermann, 2006, A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon, Am J Hum Genet, 79, 439, 10.1086/505915 Crouch, 2000, Surfactant protein-D and pulmonary host defense, Respir Res, 1, 93, 10.1186/rr19 Jovine, 2002, The ZP domain is a conserved module for polymerization of extracellular proteins, Nat Cell Biol, 4, 457, 10.1038/ncb802 Bikker, 2004, acteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains, J Biol Chem, 279, 47699, 10.1074/jbc.M406095200 Wu, 2006, The N-terminal SRCR-SID domain of gp-340 interacts with HIV type 1 gp120 sequences and inhibits viral infection, AIDS Res Hum Retroviruses, 22, 508, 10.1089/aid.2006.22.508 Ligtenberg, 2004, Binding of salivary agglutinin to IgA, Biochem J, 383, 159, 10.1042/BJ20040265 Oho, 2004, A peptide domain of bovine milk lactoferrin inhibits the interaction between streptococcal surface protein antigen and a salivary agglutinin peptide domain, Infect Immun, 72, 6181, 10.1128/IAI.72.10.6181-6184.2004 Prakobphol, 2005, Highly glycosylated human salivary molecules present oligosaccharides that mediate adhesion of leukocytes and Helicobacter pylori, Biochemistry, 44, 2216, 10.1021/bi0480180 Ligtenberg, 2000, A role for Lewis a antigens on salivary agglutinin in binding to Streptococcus mutans, Antonie Van Leeuwenhoek, 77, 21, 10.1023/A:1002054810170 Jenkinson, 1997, Structure, function and immunogenicity of streptococcal antigen I/II polypeptides, Mol Microbiol, 23, 183, 10.1046/j.1365-2958.1997.2021577.x Demuth, 1988, Cloning and expression of a Streptococcus sanguis surface antigen that interacts with a human salivary agglutinin, Infect Immun, 56, 2484, 10.1128/IAI.56.9.2484-2490.1988 Brady, 1992, Differentiation of salivary agglutinin-mediated adherence and aggregation of mutans streptococci by use of monoclonal antibodies against the major surface adhesin P1, Infect Immun, 60, 1008, 10.1128/IAI.60.3.1008-1017.1992 Crowley, 1993, Identification of a salivary agglutinin-binding domain within cell surface adhesin P1 of Streptococcus mutans, Infect Immun, 61, 1547, 10.1128/IAI.61.4.1547-1552.1993 Senpuku, 1995, An antigenic peptide inducing cross-reacting antibodies inhibiting the interaction of Streptococcus mutans PAc with human salivary components, Infect Immun, 63, 4695, 10.1128/IAI.63.12.4695-4703.1995 Jakubovics, 2005, Differential binding specificities of oral streptococcal antigen I/II family adhesins for human or bacterial ligands, Mol Microbiol, 55, 1591, 10.1111/j.1365-2958.2005.04495.x Loimaranta, 2005, Fluid- or surface-phase human salivary scavenger protein gp340 exposes different bacterial recognition properties, Infect Immun, 73, 2245, 10.1128/IAI.73.4.2245-2252.2005 Jakubovics, 2005, Functions of cell surface-anchored antigen I/II family and Hsa polypeptides in interactions of Streptococcus gordonii with host receptors, Infect Immun, 73, 6629, 10.1128/IAI.73.10.6629-6638.2005 Takamatsu, 2006, Binding of the streptococcal surface glycoproteins GspB and Hsa to human salivary proteins, Infect Immun, 74, 1933, 10.1128/IAI.74.3.1933-1940.2006 Oli, 2006, A whole cell BIAcore assay to evaluate P1-mediated adherence of Streptococcus mutans to human salivary agglutinin and inhibition by specific antibodies, J Microbiol Methods, 65, 503, 10.1016/j.mimet.2005.09.011 Hakkarainen, 2005, Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro, J Nutr, 135, 2445, 10.1093/jn/135.10.2445 Zhang, 2005, Inactivation of Streptococcus gordonii SspAB alters expression of multiple adhesin genes, Infect Immun, 73, 3351, 10.1128/IAI.73.6.3351-3357.2005 Hamada, 2004, Molecular interactions of surface protein peptides of Streptococcus gordonii with human salivary components, Infect Immun, 72, 4819, 10.1128/IAI.72.8.4819-4826.2004 Wu, 2003, Salivary agglutinin inhibits HIV type 1 infectivity through interaction with viral glycoprotein 120, AIDS Res Hum Retroviruses, 19, 201, 10.1089/088922203763315704 Wu, 2004, gp340 (SAG) binds to the V3 sequence of gp120 important for chemokine receptor interaction, AIDS Res Hum Retroviruses, 20, 600, 10.1089/0889222041217400 Hartshorn, 2006, Salivary agglutinin and lung scavenger receptor cysteine-rich glycoprotein 340 have broad anti-influenza activities and interactions with surfactant protein D that vary according to donor source and sialylation, Biochem J, 393, 545, 10.1042/BJ20050695 Eriksson, 2007, Variant size- and glycoforms of the scavenger receptor cysteine-rich protein gp-340 with differential bacterial aggregation, Glycoconj J, 24, 131, 10.1007/s10719-006-9020-1 Jonasson, 2007, Innate immunity glycoprotein gp-340 variants may modulate human susceptibility to dental caries, BMC Infect Dis, 7, 57, 10.1186/1471-2334-7-57 End, 2005, Generation of a vector system facilitating cloning of DMBT1 variants and recombinant expression of functional full-length DMBT1, Protein Expr Purif, 41, 275, 10.1016/j.pep.2005.02.010 Hardwidge, 2004, Proteomic analysis of the intestinal epithelial cell response to enteropathogenic Escherichia coli, J Biol Chem, 279, 20127, 10.1074/jbc.M401228200 Grys, 2005, The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells, Infect Immun, 73, 1295, 10.1128/IAI.73.3.1295-1303.2005 Stoddard, 2007, gp340 expressed on human genital epithelia binds HIV-1 envelope protein and facilitates viral transmission, J Immunol, 179, 3126, 10.4049/jimmunol.179.5.3126 Kellam, 2006, Infectogenomics: Insights from the host genome into infectious diseases, Cell, 124, 695, 10.1016/j.cell.2006.02.003 Pikarsky, 2004, NF-κB functions as a tumour promoter in inflammation-associated cancer, Nature, 431, 461, 10.1038/nature02924 Maeda, 2005, IKK‚ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis, Cell, 121, 977, 10.1016/j.cell.2005.04.014 Muller, 2001, Review: How was metazoan threshold crossed? The hypothetical Urmetazoa, Comp Biochem Physiol A Mol Integr Physiol, 129, 433, 10.1016/S1095-6433(00)00360-3 Muller, 1999, Towards an understanding of the molecular basis of immune responses in sponges: The marine demosponge Geodia cydonium as a model, Microsc Res Tech, 44, 219, 10.1002/(SICI)1097-0029(19990215)44:4<219::AID-JEMT3>3.0.CO;2-7 Pancer, 1997, A novel member of an ancient superfamily: Sponge (Geodia cydonium Porifera) putative protein that features scavenger receptor cysteine-rich repeats, Gene, 193, 211, 10.1016/S0378-1119(97)00135-2 Blumbach, 1998, The putative sponge aggregation receptor. Isolation and characterization of a molecule composed of scavenger receptor cysteine-rich domains and short consensus repeats, J Cell Sci, 111, 2635, 10.1242/jcs.111.17.2635 Pahler, 1998, Putative multiadhesive protein from the marine sponge Geodia cydonium: Cloning of the cDNA encoding a fibronectin-, an SRCR-, and a complement control protein module, J Exp Zool, 282, 332, 10.1002/(SICI)1097-010X(19981015)282:3<332::AID-JEZ6>3.0.CO;2-N Vila, 2000, The scavenger receptor cysteine-rich superfamily (SRCR-SF). Structure and Function of group B members, Inmunología, 19, 105 Steindler, 2007, Differential gene expression in a marine sponge in relation to its symbiotic state, Mar Biotechnol (NY), 9, 543, 10.1007/s10126-007-9024-2 Pancer, 2000, Dynamic expression of multiple scavenger receptor cysteine-rich genes in coelomocytes of the purple sea urchin, Proc Natl Acad Sci USA, 97, 13156, 10.1073/pnas.230096397 Kang, 2003, DMBT1, a regulator of mucosal homeostasis through the linking of mucosal defense and regeneration?, FEBS Lett, 540, 21, 10.1016/S0014-5793(03)00217-5